Allergies News and Research

Latest Allergies News and Research

MChip to detect H5N1

MChip to detect H5N1

Phase I clinical trial of experimental gene therapy to treat HIV shows encouraging results

Phase I clinical trial of experimental gene therapy to treat HIV shows encouraging results

The lifetime cost of current HIV care in the United States

The lifetime cost of current HIV care in the United States

Weill Cornell findings could foil two potential bioterror agents - viral peptide prevents deadly Hendra, Nipah viruses from infecting cells

Weill Cornell findings could foil two potential bioterror agents - viral peptide prevents deadly Hendra, Nipah viruses from infecting cells

FDA warns about risks of using decorative contact lenses

FDA warns about risks of using decorative contact lenses

FDA approves Omnaris, new hay fever drug

FDA approves Omnaris, new hay fever drug

Important first step towards designing new therapies for shingles

Important first step towards designing new therapies for shingles

UT Southwestern looks at promising new medication that reduces the severity and frequency of asthma attacks

UT Southwestern looks at promising new medication that reduces the severity and frequency of asthma attacks

NC State researchers receive $3.5 million to tackle HIV

NC State researchers receive $3.5 million to tackle HIV

Transport mechanism of bioactive molecule, S1P, identified

Transport mechanism of bioactive molecule, S1P, identified

Vaccine that protects mice against 1918 influenza virus developed

Vaccine that protects mice against 1918 influenza virus developed

Updates on pandemic flu vaccine trials to be presented at 44th Annual IDSA meeting

Updates on pandemic flu vaccine trials to be presented at 44th Annual IDSA meeting

New York Times examines efforts to obtain FDA approval for Abraxane to treat earlier-stage cancer

New York Times examines efforts to obtain FDA approval for Abraxane to treat earlier-stage cancer

FDA approves FluLaval

FDA approves FluLaval

Six shot course gives two year protection from hay fever

Six shot course gives two year protection from hay fever

New clues about virulence of 1918 influenza virus

New clues about virulence of 1918 influenza virus

M. D. Anderson targets asthma and allergic diseases

M. D. Anderson targets asthma and allergic diseases

Live H5N1 avian flu vaccines show promise

Live H5N1 avian flu vaccines show promise

"Allergy cells" can aggravate cancer and psoriasis

"Allergy cells" can aggravate cancer and psoriasis

Live H5N1 avian flu virus vaccines show protection in animal studies

Live H5N1 avian flu virus vaccines show protection in animal studies